ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

TELO Telomir Pharmaceuticals Inc

6.1228
0.5228 (9.34%)
Last Updated: 12:33:17
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023
USD ($)USD ($)USD ($)
Total Assets 4.77M
Total Current Assets 435k
Cash and Equivalents 1,000
Total Non-Current Assets 4.34M
Total Liabilities 1.34M
Total Current Liabilities 1.34M
Total Non-Current Liabilities 0
Common Equity 0
Retained Earnings -14.06M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 049k4.77M
Total Current Assets 049k435k
Cash and Equivalents 01,0001,000
Total Non-Current Assets -138k-937k3.44M
Total Liabilities 138k986k1.34M
Total Current Liabilities 138k986k1.34M
Total Non-Current Liabilities 000
Total Equity -138k-937k3.44M
Common Equity 000
Retained Earnings -138k-992k-14.06M

Your Recent History

Delayed Upgrade Clock